← FDA DRUG APPROVALS

FDA ANDA · ANDA212347

POTASSIUM CHLORIDE IN SODIUM CHLORIDE

sodium chloride and potassium chloride

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA212347
TYPE
ANDA
ORIGINAL APPROVAL
2020-09-17
LATEST ACTION
2020-09-17
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%Prescription
POTASSIUM CHLORIDE 150MG/100ML, SODIUM CHLORIDE 900MG/100ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%Prescription
POTASSIUM CHLORIDE 150MG/100ML, SODIUM CHLORIDE 450MG/100ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%Prescription
POTASSIUM CHLORIDE 300MG/100ML, SODIUM CHLORIDE 900MG/100ML · INJECTABLE · INJECTION

Approval history

2020-09-17UNKNOWN · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →